Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-PET: Carboplatin AUC-10 for metastatic seminoma with therapy directed by PET-CT response
2009-009882-33Phase 2Completed
- Sponsor
- St Bartholomew's and The London NHS Trust
- Start
- Jun 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin in Seminomatous germ cell testicular cancer, sponsored by St Bartholomew's and The London NHS Trust. Primary endpoint: Progression-free survival at 2 years. Started Jun 2010; status: completed.
02
Drugs
carboplatin
03
Conditions
Seminomatous germ cell testicular cancer
Beyond the preview
Go deeper on 2009-009882-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009882-33.